Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mei Pharma Inc (NQ: MEIP ) 2.900 +0.040 (+1.40%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Mei Pharma Inc < Previous 1 2 3 4 Next > Mid-Day Market Update: Nasdaq Down 1%; Icosavax Shares Plummet March 25, 2022 U.S. stocks pared gains midway through trading, with the Nasdaq Composite dropping 1% on Friday. The Dow traded up 0.02% to 34,715.99 while the NASDAQ fell 1.02% to 14,045.00... Via Benzinga Stocks That Hit 52-Week Lows On Friday March 25, 2022 On Friday, 166 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga 36 Stocks Moving In Friday's Mid-Day Session March 25, 2022 Gainers Forge Global Holdings, Inc. (NYSE: FRGE) shares jumped 66.4% to $20.70. Clever Leaves Holdings Inc. (NASDAQ: CLVR) jumped 29.1% to $2.04 after the company reported... Via Benzinga Futures Ramp To Session High As Oil Slides March 25, 2022 S&P futures were near session highs, up 0.3% or 14 points to 4,526 around the time US traders got to their desks as investors evaluated economic risks from Federal Reserve monetary-policy tightening... Via Talk Markets Penny Stocks Today: Why MEIP and HNST Are Plunging Friday March 25, 2022 We're checking in on the latest penny stocks news for today with two companies that investors are watching fall on Friday! Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For March 25, 2022 March 25, 2022 Upgrades For Aris Water Solutions Inc (NYSE:ARIS), Capital One upgraded the previous rating of Equal-Weight to Overweight. The stock has a 52-week-high of $19.16 and a 52-week-low... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session March 25, 2022 Gainers Tilray Brands (NASDAQ:TLRY) stock increased by 17.2% to $8.17 during Friday's pre-market session. The company's market cap stands at $3.9 billion. Sundial... Via Benzinga The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO March 25, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga 10 Biggest Price Target Changes For Friday March 25, 2022 Jefferies cut the price target on MEI Pharma, Inc. (NASDAQ: MEIP) from $4 to $1. MEI Pharma shares fell 44.2% to $1.01 in pre-market trading. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday March 25, 2022 Good morning, trader! Get ready for one more busy day of investing today with the biggest pre-market stock movers for Friday! Via InvestorPlace 34 Stocks Moving in Friday's Pre-Market Session March 25, 2022 Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session March 24, 2022 Gainers Via Benzinga Why MEI Pharma Stock Is Plummeting After Hours March 24, 2022 MEI Pharma Inc (NASDAQ: MEIP) shares are plunging in Thursday's after-hours session after the company provided an investor update following a recent meeting with the U.S... Via Benzinga MEI Pharma's Return On Capital Employed Insights February 14, 2022 According to data from Benzinga Pro, during Q2, MEI Pharma's (NASDAQ:MEIP) reported sales totaled $18.22 million. Despite a 51.46% increase in earnings, the company posted a loss of $5.77 million. Via Benzinga Recap: MEI Pharma Q2 Earnings February 11, 2022 MEI Pharma (NASDAQ:MEIP) reported its Q2 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings MEI Pharma beat estimated... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022 February 03, 2022 Upgrades BTIG upgraded the previous rating for Insulet Corp (NASDAQ:PODD) from Neutral to Buy. For the third quarter, Insulet had an EPS of $0.18, compared to year-ago... Via Benzinga Stocks That Hit 52-Week Lows On Thursday February 03, 2022 On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on... Via Benzinga 61 Biggest Movers From Yesterday December 03, 2021 Gainers Jowell Global Ltd. (NASDAQ: JWEL) jumped 25.5% to close at $13.36. Jowell Global recently announced a collaboration with Unilever's Uni-Excubator. Information... Via Benzinga MEI Pharma Raises $45M Via Equity Issued At 14% Discount December 02, 2021 MEI Pharma Inc (NASDAQ: MEIP) priced the underwritten public offering of 17.5 million shares at $2.60/share for gross proceeds of $45.5 million. The offer price... Via Benzinga 40 Stocks Moving In Thursday's Mid-Day Session December 02, 2021 Gainers Biofrontera Inc. (NASDAQ: BFRI) surged 39% to $6.02. Biofrontera announced Notice of Allowance for U.S. patent titled 'Illumination for Photodynamic Therapy.'... Via Benzinga Topics Intellectual Property Exposures Intellectual Property The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case December 01, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir... Via Benzinga Topics Intellectual Property Exposures COVID-19 Intellectual Property 52 Biggest Movers From Yesterday December 01, 2021 Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares climbed 128.6% to close at $5.03 on Tuesday. The FDA approved expanded labeling for Cumberland... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Tuesday's Intraday Session November 30, 2021 Gainers Cumberland (NASDAQ:CPIX) stock... Via Benzinga Mid-Afternoon Market Update: Dow Dips 500 Points; ImmunoGen Shares Spike Higher November 30, 2021 Toward the end of trading Tuesday, the Dow traded down 1.44% to 34,628.69 while the NASDAQ fell 1.34% to 15,571.16. The S&P also fell, dropping 1.36% to 4,592.03. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 35 Stocks Moving In Tuesday's Mid-Day Session November 30, 2021 Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares jumped 105.9% to $4.53. The FDA approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an... Via Benzinga Exposures Product Safety MEI Pharma, Kyowa Kirin Reveal Data From Zandelisib Trial In Follicular Lymphoma November 30, 2021 MEI Pharma Inc (NASDAQ: MEIP) and Kyowa Kirin Co Ltd have announced data from the pivotal Phase 2 TIDAL study of zandelisib as a single agent for follicular... Via Benzinga The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout November 30, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-... Via Benzinga Exposures Product Safety 40 Biggest Movers From Yesterday October 07, 2021 Gainers Volcon, Inc. (NASDAQ: VLCN) shares jumped 97.5% to settle at $10.86 on Wednesday as the company priced its IPO at $5.50 per share. Voyager Therapeutics, Inc. (NASDAQ:... Via Benzinga Topics Initial Public Offering Exposures Securities Market 12 Health Care Stocks Moving In Wednesday's Intraday Session October 06, 2021 Gainers Voyager Therapeutics (NASDAQ:VYGR) shares moved upwards by 44.73% to $3.58 during Wednesday's regular session. Voyager Therapeutics's stock is trading at a... Via Benzinga The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab September 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... Via Benzinga Exposures COVID-19 Product Safety < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.